Studies have also shown that calcitriol is capable of inhibiting NLRP3 inflammasome activation and its downstream cytokine signaling in mouse models of liver injury and fibrosis (72), ulcerative colitis (73), and diabetic retinopathy (74). This evidence concerns the gene NLRP3 and ulcerative colitis.